Seer Inc (SEER) Stock Analysis

Seer Inc (SEER) is a publicly traded company in the HEALTHCARE sector. It trades at $1.88, carries a market capitalization of $102.82M. This page summarizes the public market data, fundamentals, and frequently asked questions for SEER, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.88
• Market Cap: $102.82M
• EPS: $-1.24
• 52-Week High: $2.41
• 52-Week Low: $1.65

Market Sentiment

Seer Inc currently has a Neutral sentiment score of -0.07.

About Seer Inc

Seer, Inc., headquartered in Redwood City, California, is at the forefront of life sciences innovation, dedicated to revolutionizing biological data analysis through its proprietary proteomics technologies. The company's advanced platforms enable researchers to gain unprecedented insights into biology, thereby facilitating breakthroughs in drug discovery and disease understanding. With a strong commitment to enhancing scientific capabilities, Seer is poised to significantly impact the future ...

GNG Research Analysis

GNG Research scores Seer Inc (SEER) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SEER.

Frequently Asked Questions

Does SEER pay dividends?

Seer Inc (SEER) does not currently pay a regular dividend.

What is SEER's market cap?

Seer Inc (SEER) has a market capitalization of $102.82M with a current stock price of $1.88.